Factors to Consider When Choosing Treatment for ET, PV and MF

Description: At a recent town meeting in partnership with Robert H. Lurie Comprehensive Cancer Center in Chicago, Dr. Brady Stein helps viewers understand what should be considered when choosing a treatment plan for those with essential thrombocythemia (ET), polycythemia vera (PV) and myelofibrosis (MF). Dr. Stein talks about factors such as symptoms and risk. He goes on to provide considerations for each of the myeloproliferative neoplasms (MPNs).

Get email alerts | http://www.patientpower.inf...

Subscribe on YouTube |
Like on Facebook |
Follow on Twitter |
Follow on Google+ |
Shared By : P2Professional
Posted on : 08/14/17
Added : 2 years ago